Sitosterolemia, a rare genetic disorder affecting how the body absorbs plant sterols, often goes undiagnosed because it first appears as blood problems like anemia and low platelet counts rather than the classic signs of heart disease. According to Gram Research analysis of six patients with confirmed sitosterolemia, all showed distinctive blood cell abnormalities and genetic mutations in genes controlling plant sterol absorption. Four patients improved significantly within 4 to 12 months after starting a plant sterol-restricted diet and ezetimibe medication, suggesting early diagnosis and treatment can reverse blood abnormalities and prevent unnecessary misdiagnosis.

A new study reveals that sitosterolemia, a rare genetic disorder affecting how the body handles plant sterols, often goes undiagnosed because it first shows up as blood problems like anemia and low platelet counts. Researchers at a major medical center studied six patients who were initially misdiagnosed with more common blood disorders before genetic testing revealed the true cause. All patients improved with dietary changes and medication. The findings highlight the importance of considering sitosterolemia when patients have unexplained blood abnormalities, potentially saving them from unnecessary tests and treatments.

Key Statistics

A 2026 case series of six sitosterolemia patients found that all presented with unexplained anemia and low platelet counts, yet were initially misdiagnosed with more common blood disorders like immune thrombocytopenia and iron-deficiency anemia.

In a 2026 study of six sitosterolemia patients, four showed improvements in hemoglobin levels, platelet counts, and spleen size within 4 to 12 months of treatment with dietary modification and ezetimibe medication.

A 2026 analysis of six patients with genetically confirmed sitosterolemia found that five carried mutations in the ABCG8 gene and one in the ABCG5 gene, with all patients displaying distinctive stomatocytes and giant platelets on blood smears.

The Quick Take

  • What they studied: How sitosterolemia, a rare inherited disorder, shows up as blood problems and why doctors often miss the diagnosis initially.
  • Who participated: Six patients (three men and three women, average age 40) who came to a major hospital with blood abnormalities between 2024 and 2026.
  • Key finding: All six patients had genetic mutations in genes controlling how the body absorbs plant sterols. Four patients showed improvement in blood counts and spleen size within 4 to 12 months after starting treatment with diet changes and medication.
  • What it means for you: If you have unexplained anemia or low platelet counts, ask your doctor about sitosterolemia testing. Early diagnosis allows for simple dietary changes and medication that can improve your condition, avoiding unnecessary treatments for misdiagnosed conditions.

The Research Details

Researchers reviewed medical records of six patients treated at a major hospital between January 2024 and June 2026 who had sitosterolemia confirmed by genetic testing. They collected information about each patient’s symptoms, blood test results, genetic mutations, treatments received, and how well they responded to treatment over time. This type of study, called a case series, examines a small group of patients with the same condition to identify patterns and improve understanding of how the disease appears and responds to treatment. The researchers looked back at existing medical records rather than following patients forward in time, which is a practical approach for studying rare diseases where few patients are available.

Sitosterolemia is so rare that many doctors have never seen a case. Patients often get misdiagnosed with more common blood disorders like immune thrombocytopenia or iron-deficiency anemia, leading to wrong treatments and delays in proper care. By documenting how sitosterolemia actually presents in real patients, this study helps doctors recognize the condition earlier. Understanding the genetic basis and how patients respond to treatment also guides future care decisions.

This study is based on careful review of actual patient records from a specialized medical center, which makes the clinical observations reliable. However, the small sample size of six patients means findings may not apply to all sitosterolemia patients. The study includes one newly discovered genetic mutation that needs further research to confirm its role in disease. Follow-up information was incomplete for two patients, which limits understanding of long-term outcomes.

What the Results Show

All six patients presented with blood abnormalities including anemia (low red blood cells), thrombocytopenia (low platelets), and enlarged spleens. When doctors examined blood samples under a microscope, they found distinctive abnormal red blood cells called stomatocytes and unusually large platelets in all patients. Genetic testing revealed mutations in two genes that control how the body absorbs plant sterols: five patients had mutations in the ABCG8 gene and one had mutations in the ABCG5 gene. Notably, one patient carried a previously unknown mutation that researchers are still studying. Three patients also had tendon xanthomas (fatty deposits in tendons), and one had premature heart disease, which are classic signs of sitosterolemia that doctors should have recognized earlier.

The study found that patients were initially misdiagnosed with various common blood disorders, including immune thrombocytopenia, iron-deficiency anemia, megaloblastic anemia, and Evans syndrome. This diagnostic delay meant patients received unnecessary treatments before the correct diagnosis. The research also identified that ABCG8 mutations were more common than ABCG5 mutations in this patient group, though both genes can cause the disease.

Sitosterolemia is classically known for causing xanthomas and early heart disease, but this study confirms what some researchers have suspected: blood abnormalities can be the first sign of the disease. Previous literature focused mainly on heart and cholesterol problems, potentially causing doctors to overlook blood-related presentations. This research adds important information about how the disease appears in real patients and supports the idea that genetic testing should be considered in unexplained blood disorders.

The study included only six patients from one medical center, so results may not represent all sitosterolemia patients worldwide. Two patients did not have complete follow-up information, making it impossible to assess their long-term outcomes. The study is retrospective, meaning researchers looked back at past records rather than following patients forward, which can miss some details. The newly discovered genetic mutation needs additional research to confirm it actually causes disease. The small sample size means doctors should not assume all sitosterolemia patients will respond to treatment exactly as these six did.

The Bottom Line

Doctors should consider sitosterolemia testing in patients with unexplained anemia, low platelet counts, enlarged spleens, and distinctive blood cell abnormalities. Treatment with a phytosterol-restricted diet (limiting plant-based sterols) combined with ezetimibe medication appears effective based on this study. Confidence in these recommendations is moderate because the study is small, but the clinical improvement seen in four patients is encouraging. Genetic counseling is recommended for diagnosed patients and their families.

This information matters most for people with unexplained blood disorders, their doctors, and families with a history of rare genetic diseases. Hematologists (blood specialists) and cardiologists should be aware that sitosterolemia can present as blood problems. Patients who have been diagnosed with immune thrombocytopenia or other blood disorders without clear cause should ask about sitosterolemia testing. Family members of diagnosed patients should consider genetic screening.

Based on this study, patients showed improvements in blood counts and spleen size within 4 to 12 months of starting treatment. However, individual responses may vary. Long-term monitoring is important to ensure treatment effectiveness and prevent heart complications.

Frequently Asked Questions

What is sitosterolemia and how does it affect the blood?

Sitosterolemia is a rare inherited disorder where the body absorbs too many plant sterols and cannot eliminate them properly. This causes abnormal red and white blood cells, low platelet counts, and enlarged spleens, often leading to anemia and bleeding problems.

Why do doctors often miss sitosterolemia diagnosis?

Sitosterolemia is extremely rare, so doctors typically think of more common conditions first. Patients present with blood problems rather than the classic signs of heart disease, causing misdiagnosis with immune thrombocytopenia or iron-deficiency anemia, delaying proper treatment.

How is sitosterolemia treated and does it work?

Treatment involves restricting plant sterols in the diet and taking ezetimibe medication. A 2026 study found that four of six patients improved significantly within 4 to 12 months, showing increased red blood cells, higher platelet counts, and reduced spleen size.

Should I get tested for sitosterolemia if I have unexplained anemia?

If you have persistent anemia or low platelet counts without a clear cause, ask your doctor about sitosterolemia testing, especially if you also have an enlarged spleen or distinctive blood cell abnormalities on microscopy.

Is sitosterolemia inherited and can family members get it?

Yes, sitosterolemia is autosomal recessive, meaning both parents must carry a mutated gene for a child to develop the disease. Family members of diagnosed patients should consider genetic screening and counseling.

Want to Apply This Research?

  • Track weekly hemoglobin levels, platelet counts, and spleen size measurements if you have sitosterolemia. Record dietary adherence to phytosterol restrictions and medication compliance with ezetimibe. Note any symptoms like fatigue, bruising, or abdominal discomfort.
  • Users diagnosed with sitosterolemia should use the app to log daily dietary choices, specifically avoiding high-phytosterol foods like nuts, seeds, vegetable oils, and whole grains. Set reminders for ezetimibe medication doses. Track energy levels and bleeding symptoms to monitor treatment effectiveness.
  • Establish a monthly check-in system with blood test results from your doctor. Create a trend chart showing hemoglobin and platelet counts over time. Set quarterly review dates to assess whether dietary changes and medication are working. Share reports with your healthcare provider to guide treatment adjustments.

This article summarizes research findings about sitosterolemia and should not be used for self-diagnosis or to replace professional medical advice. Sitosterolemia is a rare condition that requires confirmation through genetic testing by a qualified healthcare provider. If you suspect you may have sitosterolemia or experience unexplained blood abnormalities, consult with a hematologist or your primary care physician. Treatment decisions should be made in consultation with your medical team based on your individual circumstances. This information is current as of the publication date but medical knowledge evolves; always seek the most recent guidance from your healthcare provider.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: Sitosterolemia presenting as unexplained cytopenias: hematologic manifestations and genetic spectrum. , Blood research (2026). PubMed 42825986 | DOI
Topics
sitosterolemia rare genetic disorder anemia low platelet count plant sterols genetic mutation ezetimibe treatment blood disorder diagnosis